Literature DB >> 2878940

Susceptibility to multiple sclerosis associated with an immunoglobulin gamma 3 restriction fragment length polymorphism.

C N Gaiser, M J Johnson, G de Lange, L Rassenti, L L Cavalli-Sforza, L Steinman.   

Abstract

Susceptibility to multiple sclerosis (MS) has been linked to the immunoglobulin G (Gm) markers as well as HLA-DR genes. We have used a genomic Ig gamma 1 probe which detects polymorphisms in the gamma 1, gamma 2, gamma 3 and pseudogamma genes to identify restriction fragment length polymorphisms associated with MS. A negative association was found between a 5.9-kilobase (kb) Bst EII gamma 3 fragment and MS. Southern blot analysis of genomic DNA revealed the presence of this fragment in 84 of 140 (60.0%) controls, but in only 17 of 59 (28.8%) MS patients. The frequency of the fragment in 47 myasthenia gravis and 16 Graves' disease patients was similar to that in controls, 60.0 and 62.5%, respectively.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 2878940      PMCID: PMC424051          DOI: 10.1172/JCI112801

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  46 in total

1.  HLA antigens in multiple sclerosis.

Authors:  C Brautbar; M Alter; E Kahana
Journal:  Neurology       Date:  1976-06       Impact factor: 9.910

2.  Two major genes, linked to HLA and Gm, control susceptibility to Graves' disease.

Authors:  H Uno; T Sasazuki; H Tamai; H Matsumoto
Journal:  Nature       Date:  1981-08-20       Impact factor: 49.962

3.  IgG heavy-chain (Gm) allotypes and immune response to insulin in insulin-requiring diabetes mellitus.

Authors:  Y Nakao; H Matsumoto; T Miyazaki; N Mizuno; N Arima; A Wakisaka; K Okimoto; Y Akazawa; K Tsuji; T Fujita
Journal:  N Engl J Med       Date:  1981-02-12       Impact factor: 91.245

4.  Immunoglobulin G heavy chain (Gm) allotypes in multiple sclerosis.

Authors:  J P Pandey; J M Goust; J P Salier; H H Fudenberg
Journal:  J Clin Invest       Date:  1981-06       Impact factor: 14.808

5.  Interactive effect of Gm allotypes and HLA-B locus antigens on the human antibody response to a bacterial antigen.

Authors:  S Whittingham; J D Mathews; M S Schanfield; J V Matthews; B D Tait; P J Morris; I R Mackay
Journal:  Clin Exp Immunol       Date:  1980-04       Impact factor: 4.330

6.  Interaction of HLA and Gm in autoimmune chronic active hepatitis.

Authors:  S Whittingham; J D Mathews; M S Schanfield; B D Tait; I R Mackay
Journal:  Clin Exp Immunol       Date:  1981-01       Impact factor: 4.330

7.  Preferential synthesis of the G1m(1) allotype of IgG1 in the central nervous system of multiple sclerosis patients.

Authors:  J P Salier; J M Goust; J P Pandey; H H Fudenberg
Journal:  Science       Date:  1981-09-18       Impact factor: 47.728

8.  IgG heavy chain allotypes (Gm) in autoimmune diseases.

Authors:  Y Nakao; H Matsumoto; T Miyazaki; H Nishitani; K Takatsuki; R Kasukawa; S Nakayama; S Izumi; T Fujita; K Tsuji
Journal:  Clin Exp Immunol       Date:  1980-10       Impact factor: 4.330

9.  Immunoglobulin allotypes and response to tetanus toxoid in Papua, New Guinea.

Authors:  M S Schanfield; J V Wells; H H Fudenberg
Journal:  J Immunogenet       Date:  1979-10

10.  Measles antibody titers in multiple sclerosis patients and HLA-matched and unmatched siblings.

Authors:  B R Visscher; C B Sullivan; R Detels; D L Madden; J L Sever; P I Terasaki; M S Park; J P Dudley
Journal:  Neurology       Date:  1981-09       Impact factor: 9.910

View more
  14 in total

1.  Immunoglobulin heavy chain gene associations in myasthenia gravis: new evidence for disease heterogeneity.

Authors:  A Demaine; N Willcox; M Janer; K Welsh; J Newsom-Davis
Journal:  J Neurol       Date:  1992-01       Impact factor: 4.849

Review 2.  Gm allotype system and autoimmune diseases.

Authors:  M Abu-Shakra; Y Shoenfeld
Journal:  Immunol Res       Date:  1989       Impact factor: 2.829

3.  A highly informative probe for two polymorphic Vh gene regions that contain one or more autoantibody-associated Vh genes.

Authors:  P P Chen; K A Siminovitch; N J Olsen; R A Erger; D A Carson
Journal:  J Clin Invest       Date:  1989-08       Impact factor: 14.808

4.  T-cell receptor V alpha and C alpha alleles associated with multiple and myasthenia gravis.

Authors:  J R Oksenberg; M Sherritt; A B Begovich; H A Erlich; C C Bernard; L L Cavalli-Sforza; L Steinman
Journal:  Proc Natl Acad Sci U S A       Date:  1989-02       Impact factor: 11.205

Review 5.  DNA polymorphism and the study of disease associations.

Authors:  D N Cooper; J F Clayton
Journal:  Hum Genet       Date:  1988-04       Impact factor: 4.132

6.  Genetic linkage of autosomal recessive canine narcolepsy with a mu immunoglobulin heavy-chain switch-like segment.

Authors:  E Mignot; C Wang; C Rattazzi; C Gaiser; M Lovett; C Guilleminault; W C Dement; F C Grumet
Journal:  Proc Natl Acad Sci U S A       Date:  1991-04-15       Impact factor: 11.205

7.  Susceptibility to multiple sclerosis is associated with the proximal immunoglobulin heavy chain variable region.

Authors:  M A Walter; W T Gibson; G C Ebers; D W Cox
Journal:  J Clin Invest       Date:  1991-04       Impact factor: 14.808

8.  Susceptibility to multiple sclerosis and the immunoglobulin heavy chain variable region.

Authors:  N W Wood; S J Sawcer; H F Kellar-Wood; P Holmans; D Clayton; N Robertson; D A Compston
Journal:  J Neurol       Date:  1995-10       Impact factor: 4.849

Review 9.  Insights into the immunopathogenesis of multiple sclerosis.

Authors:  Niels Hellings; Jef Raus; Piet Stinissen
Journal:  Immunol Res       Date:  2002       Impact factor: 2.829

10.  IgH (mu-switch and gamma-1) region restriction fragment length polymorphism in human narcolepsy.

Authors:  S M Singh; C F George; R N Ott; C Rattazzi; C Guilleminault; W C Dement; E Mignot
Journal:  J Clin Immunol       Date:  1996-07       Impact factor: 8.317

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.